RNAi-mediated Gene Silencing of Mutant Myotilin Improves Myopathy in LGMD1A Mice

Recent progress suggests gene therapy may one day be an option for treating some forms of limb girdle muscular dystrophy (LGMD). Nevertheless, approaches targeting LGMD have so far focused on gene replacement strategies for recessive forms of the disease. In contrast, no attempts have been made to d...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jian, Wallace, Lindsay M, Garwick-Coppens, Sara E, Sloboda, Darcée D, Davis, Carol S, Hakim, Chady H, Hauser, Michael A, Brooks, Susan V, Mendell, Jerry R, Harper, Scott Q
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013433/
https://www.ncbi.nlm.nih.gov/pubmed/24781192
http://dx.doi.org/10.1038/mtna.2014.13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013433/
https://www.ncbi.nlm.nih.gov/pubmed/24781192
http://dx.doi.org/10.1038/mtna.2014.13

Ejemplares similares